Key Account Manager, Nomic Bio
+ Performance-based commissions & equity participation (pre-IPO)
Travel ~50% as needed
Protein profiling company
Be an early applicant
Protein profiling company
21-100 employees
Be an early applicant
+ Performance-based commissions & equity participation (pre-IPO)
Travel ~50% as needed
21-100 employees
Company mission
Their mission is to empower scientists to increase the scope and scale of their experiments.
Role
Who you are
- Experience: 5+ years in technical or strategic sales within Pharma/Biotech, with a proven track record of meeting or exceeding targets
- Background: Strong scientific foundation (MS or PhD in Molecular Biology, Biochemistry, Immunology, or related field preferred)
- Commercial Skills: Enterprise-level selling experience with Big Pharma, ideally within proteomics, biomarkers, or drug discovery technology
- Technical Fluency: Ability to credibly discuss proteomic use cases in drug discovery, translational biomarkers, and clinical development
- Network: Established relationships across Translational Biomarkers, Target Discovery, and Clinical Biomarkers functions strongly preferred
- Sales Style: Proactive, consultative, and strategic, with the ability to influence decision-makers across scientific and executive levels
- Travel: Willingness to travel ~50% as needed
What the job involves
- We are seeking a Key Account Manager to drive expansion across leading pharmaceutical organizations in drug discovery and translational biomarkers
- This is a strategic, high-impact commercial role blending technical acumen with enterprise-level account leadership
- You will own and grow key accounts, developing deep relationships with executive stakeholders while ensuring technical credibility with bench-level scientists
- You will act as the primary point of contact for major Pharma accounts, leading cross-functional sales cycles, shaping account strategies, and unlocking new opportunities
- This position requires equal parts technical fluency, consultative selling, and strategic enterprise management
- Lead expansion of major pharmaceutical accounts, including existing high-value partnerships
- Engage directly with senior stakeholders (VPs, Directors, Heads of Translational Science/Biomarkers) to advance adoption of proteomic solutions
- Serve as a trusted partner, aligning Nomic’s platform capabilities with critical customer needs in drug discovery and translational research
- Coordinate with internal technical and scientific teams to deliver customer success and ensure long-term account growth
- Own and expand relationships with top pharmaceutical accounts, developing and executing account-specific strategies
- Prospect and engage new customers within the biopharma space, generating net-new business
- Lead high-level conversations with senior executives while also delivering technical presentations to scientific teams
- Manage complex sales cycles, balancing strategic enterprise penetration with shorter transactional opportunities
- Provide scientific and commercial insights that influence customer decision-making and adoption of proteomic technologies
- Partner closely with internal Field Application Scientists, Technical Sales Managers, and Product teams to deliver impactful solutions
- Represent Nomic at key industry and academic conferences as both a business and technical commercial lead
- Maintain accurate pipeline visibility and forecasting through CRM and funnel management
Our take
For bioscientists, quantifying multiple proteins at the same time is expensive and time-consuming. Nomic solves this problem with its proteomic platform, nELISA.
First launched as nplex biosciences, Nomic has since rebranded, fueled by an impressive $17 million in funding. This has allowed the company to accelerate its research considerably. Nomic works with a range of top-tier pharma companies and research institutes, which is testament to the demand for their product.
Nomic will need to continue to draw top talent to their ranks, and to attract even more funding, if they are to research and roll out their product effectively.
Freddie
Company Specialist at Welcome to the Jungle
Company
Funding (last 2 of 4 rounds)
Sep 2024
$42m
SERIES B
Dec 2021
$17m
SERIES A
Total funding: $60.2m
Company HQ
Milton Park, Montreal, QC
Leadership
Milad Dagher
(CEO)Holds a PhD in Biological and Biomedical Engineering from McGill.
Jeff Munzar
(Head of Technology)Was previously CEO & Co-founder of Fetch Biosciences.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job